For citations:
Kudryashova A.M., Grebenkin D.Yu., Samsonov M.Yu., Filon O.V., Razzhivina V.A., Chernobrovkin M.G., Borisova O.V. Development and validation of an ELISA-based method for determining neutralizing antibodies to pembrolizumab in human serum based on inhibition of the drug binding to its PD-1 target. Medical Immunology (Russia). 2025;27(6):1423-1434. (In Russ.) https://doi.org/10.15789/1563-0625-DAV-3188
Email this article 